Lenacapavir is a first-in-class HIV-1 capsid inhibitor, classified as an antiretroviral medication used in combination therapy to treat multidrug-resistant HIV-1 infection. This category features a comprehensive… Read more








![Chemical structure of N-((S)-1-(3-(3-amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bR,4aS)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3098575-22-2-N-S-1-3-3-amino-4-chloro-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophenyleth.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(3-Amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2375020-20-3-N-S-1-3-3-Amino-4-chloro-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophenyleth.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-((chloromethyl)sulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-S-1-3-4-Chloro-3-chloromethylsulfonamido-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophen.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-((hydroxymethyl)amino)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-S-1-3-4-Chloro-3-hydroxymethylamino-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophenyleth.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-(methylamino)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3081998-23-1-N-S-1-3-4-Chloro-3-methylamino-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophe.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5-oxo-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-S-1-3-4-Chloro-3-methylsulfonamido-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophenylethy.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methylbut-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-S-1-3-4-Chloro-3-methylsulfonamido-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophenylethyl-2-3bS4aR-55-dif.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methylbut-3-en-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-S-1-3-4-Chloro-3-methylsulfonamido-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methylbut-3-en-1-yn-1-ylpyridin-2-yl-2-35-difluorophenylethyl-2-3bS4aR-5.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-(N-(methylsulfonyl)methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2189684-58-8-N-S-1-3-4-Chloro-3-N-methylsulfonylmethylsulfonamido-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-(N-ethylmethylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3025145-48-3-N-S-1-3-4-Chloro-3-N-ethylmethylsulfonamido-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-3.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-(4-Chloro-3-(N-methylmethylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2939763-16-1-N-S-1-3-4-Chloro-3-N-methylmethylsulfonamido-1-222-trifluoroethyl-1H-indazol-7-yl-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-.png&w=3840&q=75)
![Chemical structure of N-((S)-1-(3-Bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2375020-19-0-N-S-1-3-Bromo-6-3-methyl-3-methylsulfonylbut-1-yn-1-ylpyridin-2-yl-2-35-difluorophenylethyl-2-3bS4aR-55-difluoro-3-trifluoromethyl-3b44a5.png&w=3840&q=75)



Lenacapavir is a first-in-class HIV-1 capsid inhibitor, classified as an antiretroviral medication used in combination therapy to treat multidrug-resistant HIV-1 infection. This category features a comprehensive range of Lenacapavir reference standards, impurities, metabolites, and stable isotope labelled compounds essential for rigorous pharmaceutical analysis. These high-quality compounds are critical for accurate impurity profiling, method validation, and quality control, supporting laboratories in identifying and quantifying process-related impurities and degradation products that may arise during synthesis or from environmental stress factors such as hydrolysis and oxidation. By providing structurally characterized reference materials, this collection facilitates regulatory compliance and helps ensure the potency, stability, and safety of the drug throughout its lifecycle. Analytical chemists utilize these standards to develop robust methods for the assessment of related substances, ensuring precise monitoring of drug quality and supporting ongoing research into the efficacy of this long-acting capsid inhibitor.